Literature DB >> 27465235

Generated effect modifiers (GEM's) in randomized clinical trials.

Eva Petkova1, Thaddeus Tarpey2, Zhe Su3, R Todd Ogden4.   

Abstract

In a randomized clinical trial (RCT), it is often of interest not only to estimate the effect of various treatments on the outcome, but also to determine whether any patient characteristic has a different relationship with the outcome, depending on treatment. In regression models for the outcome, if there is a non-zero interaction between treatment and a predictor, that predictor is called an "effect modifier". Identification of such effect modifiers is crucial as we move towards precision medicine, that is, optimizing individual treatment assignment based on patient measurements assessed when presenting for treatment. In most settings, there will be several baseline predictor variables that could potentially modify the treatment effects. This article proposes optimal methods of constructing a composite variable (defined as a linear combination of pre-treatment patient characteristics) in order to generate an effect modifier in an RCT setting. Several criteria are considered for generating effect modifiers and their performance is studied via simulations. An example from a RCT is provided for illustration.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Biosignature; Moderator; Precision medicine; Treatment decision; Value

Mesh:

Year:  2016        PMID: 27465235      PMCID: PMC5255046          DOI: 10.1093/biostatistics/kxw035

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  22 in total

1.  A multivariate test of interaction for use in clinical trials.

Authors:  D A Follmann; M A Proschan
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

3.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.

Authors:  Helena Chmura Kraemer
Journal:  Stat Med       Date:  2013-01-10       Impact factor: 2.373

4.  Estimation of treatment policies based on functional predictors.

Authors:  Ian W McKeague; Min Qian
Journal:  Stat Sin       Date:  2014-07       Impact factor: 1.261

5.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

6.  Detecting treatment-covariate interactions using permutation methods.

Authors:  Rui Wang; David A Schoenfeld; Bettina Hoeppner; A Eden Evins
Journal:  Stat Med       Date:  2015-03-02       Impact factor: 2.373

7.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Ying-Qi Zhao; Donglin Zeng; Eric B Laber; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

8.  Combining biomarkers to optimize patient treatment recommendations.

Authors:  Chaeryon Kang; Holly Janes; Ying Huang
Journal:  Biometrics       Date:  2014-05-30       Impact factor: 2.571

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Survival prediction based on compound covariate under Cox proportional hazard models.

Authors:  Takeshi Emura; Yi-Hau Chen; Hsuan-Yu Chen
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more
  8 in total

1.  A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.

Authors:  Sigal Zilcha-Mano; Steven P Roose; Patrick J Brown; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2018-01-11       Impact factor: 4.105

2.  A single-index model with multiple-links.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Stat Plan Inference       Date:  2019-07-04       Impact factor: 1.111

3.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Authors:  David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

Review 4.  The concept of justifiable healthcare and how big data can help us to achieve it.

Authors:  Wim van Biesen; Catherine Van Der Straeten; Sigrid Sterckx; Johan Steen; Lisa Diependaele; Johan Decruyenaere
Journal:  BMC Med Inform Decis Mak       Date:  2021-03-06       Impact factor: 2.796

5.  Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.

Authors:  Hyung Park; Thaddeus Tarpey; Mengling Liu; Keith Goldfeld; Yinxiang Wu; Danni Wu; Yi Li; Jinchun Zhang; Dipyaman Ganguly; Yogiraj Ray; Shekhar Ranjan Paul; Prasun Bhattacharya; Artur Belov; Yin Huang; Carlos Villa; Richard Forshee; Nicole C Verdun; Hyun Ah Yoon; Anup Agarwal; Ventura Alejandro Simonovich; Paula Scibona; Leandro Burgos Pratx; Waldo Belloso; Cristina Avendaño-Solá; Katharine J Bar; Rafael F Duarte; Priscilla Y Hsue; Anne F Luetkemeyer; Geert Meyfroidt; André M Nicola; Aparna Mukherjee; Mila B Ortigoza; Liise-Anne Pirofski; Bart J A Rijnders; Andrea Troxel; Elliott M Antman; Eva Petkova
Journal:  JAMA Netw Open       Date:  2022-01-04

6.  Statistical Analysis Plan for Stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) Study.

Authors:  Eva Petkova; R Todd Ogden; Thaddeus Tarpey; Adam Ciarleglio; Bei Jiang; Zhe Su; Thomas Carmody; Philip Adams; Helena C Kraemer; Bruce D Grannemann; Maria A Oquendo; Ramin Parsey; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Madhukar H Trivedi
Journal:  Contemp Clin Trials Commun       Date:  2017-02-24

7.  Optimising treatment decision rules through generated effect modifiers: a precision medicine tutorial.

Authors:  Eva Petkova; Hyung Park; Adam Ciarleglio; R Todd Ogden; Thaddeus Tarpey
Journal:  BJPsych Open       Date:  2019-12-03

Review 8.  Predictive approaches to heterogeneous treatment effects: a scoping review.

Authors:  Alexandros Rekkas; Jessica K Paulus; Gowri Raman; John B Wong; Ewout W Steyerberg; Peter R Rijnbeek; David M Kent; David van Klaveren
Journal:  BMC Med Res Methodol       Date:  2020-10-23       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.